AstraZeneca Exercises License Option For Oncolytic Virus Generated From Invir.IO Collaboration
15/12 07:46
(RTTNews) - Transgene said that AstraZeneca (AZN, AZN.L) has exercised its first license option for an Invir.IO oncolytic virus or OV developed from their on-going OV collaboration....